Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01342341 · ClinicalTrials.gov registry record · Phase 4
Placebo-Controlled Cross Over Trial of Chlorzoxazone Intake
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
NCT01342341 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 48 participants.
The verdict
NCT01342341, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
Study Summary
The overall goals of this study are to (1) expand knowledge about interactions of chlorzoxazone with alcohol by assessing the effects of chlorzoxazone compared to placebo in moderate and heavy social alcohol users and (2) to compare the effects of chlorzoxazone on visual cue induced alcohol craving to placebo in moderate to heavy social alcohol users.
Interventions
- DRUG Parafon Forte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01342341
The ClinicalTrials.gov registry entry for NCT01342341 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Parafon Forte is the first listed.
NCT01342341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01342341 about?
NCT01342341 is a clinical study titled "Placebo-Controlled Cross Over Trial of Chlorzoxazone Intake". The overall goals of this study are to (1) expand knowledge about interactions of chlorzoxazone with alcohol by assessing the effects of chlorzoxazone compared to placebo in moderate and heavy social alcohol users and (2) to compare the effects of chlorzoxazone on visual cue induced alcohol craving ...
What is the current status of trial NCT01342341?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2011-04. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01342341?
The interventions under investigation include: Parafon Forte (DRUG).
Who is sponsoring clinical trial NCT01342341?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.